In summary, our findings indicate that obesity is linked to high TSPO expression specifically in females with AD, which implies that high TSPO-PET levels deserve distinct interpretation among sexes. This evidence concerns the gene TSPO and obesity due to melanocortin 4 receptor deficiency.